Figure 5.
Immunoreactivity of LDL as a function of the time of glycation. The reactivity of LDL that had been modified under the conditions described in Fig. 4 with anti-apoB and anti-AGE mAbs was determined by Western blotting analysis. Results with the anti-AGE mAb, 4G9, and anti-apoB mAbs 1D1, 2D8, and 4G3 are presented.